Evidence map›Paper›PMID 40276974›Full record

ArticleNucleic acids research2025

antiSMASH 8.0: extended gene cluster detection capabilities and analyses of chemistry, enzymology, and regulation.

Kai Blin, Simon Shaw, Lisa Vader, Judit Szenei, Zachary L Reitz, Hannah E Augustijn, José D D Cediel-Becerra, Valérie de Crécy-Lagard, Robert A Koetsier, Sam E Williams and 17 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 403 papers.

0numbers the graph read from it
0cells of the map it votes in
403citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

403 citing papers in PubMed.

  1. Article
  2. Article
  3. Biosynthetic origin of anticancer dolastatin 15 reveals a noncanonical NRPS architecture enabling 2-keto acid activation.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Review
  5. New microbes and new infections · 2026
    Article
  6. Article
  7. Data-driven optimization of siderophore fermentation byApplied and environmental microbiology · 2026
    Article
  8. Article
  9. The Oxytetracycline ProducerInternational journal of molecular sciences · 2026
    Article
  10. Structural and Functional Siderophore Remodeling by Enzymatic Delipidation.Angewandte Chemie (International ed. in English) · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Draft genome sequence ofMicrobiology resource announcements · 2026
    Article
  17. Comparative Genome Mining ofMarine drugs · 2026
    Article
  18. Article
  19. Complete genome sequence ofMicrobiology resource announcements · 2026
    Article
  20. Complete genome sequence ofMicrobiology resource announcements · 2026
    Article

343 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Kai BlinThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2950 Kongens Lyngby, Denmark.ORCID 0000-0003-3764-6051
Simon ShawThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2950 Kongens Lyngby, Denmark.
Lisa VaderThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2950 Kongens Lyngby, Denmark.ORCID 0009-0008-5454-3306
Judit SzeneiThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2950 Kongens Lyngby, Denmark.ORCID 0009-0006-9871-5187
Zachary L ReitzDepartment of Ecology, Evolution and Marine Biology, University of California, 1169 Biological Sciences II, Santa Barbara, CA 93106, United States.ORCID 0000-0003-1964-8221
Hannah E AugustijnInstitute of Biology, Leiden University, Sylviusweg 72, 2333 BE Leiden, the Netherlands.ORCID 0000-0002-1862-6699
José D D Cediel-BecerraDepartment of Microbiology and Cell Science, University of Florida, 1355 Museum Dr, Gainesville, FL 32603, United States.ORCID 0000-0001-6496-2071
Valérie de Crécy-LagardDepartment of Microbiology and Cell Science, University of Florida, 1355 Museum Dr, Gainesville, FL 32603, United States.ORCID 0000-0002-9955-3785
Robert A KoetsierBioinformatics Group, Wageningen University & Research, Droevendaalsesteeg 1, 6708 PB Wageningen, the Netherlands.
Sam E WilliamsThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2950 Kongens Lyngby, Denmark.ORCID 0000-0002-6949-426X
Pablo Cruz-MoralesThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2950 Kongens Lyngby, Denmark.ORCID 0000-0002-6751-8897
Sopida WongwasSchool of Life Sciences, University of Warwick, Coventry CV4 7AL, United Kingdom.ORCID 0000-0002-5770-9745
Alejandro E Segurado LuchsingerVIB-KU Leuven Center for Microbiology, Kasteelpark Arenberg 31, 3001 Leuven, Belgium.ORCID 0000-0002-2364-3143
Friederike BiermannBioinformatics Group, Wageningen University & Research, Droevendaalsesteeg 1, 6708 PB Wageningen, the Netherlands.ORCID 0000-0002-9152-2562
Aleksandra KorenskaiaInterfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT), Interfaculty Institute for Biomedical Informatics (IBMI), University of Tübingen, Auf der Morgenstelle 24, 72076 Tübingen, Germany.ORCID 0000-0003-3002-6458
Mitja M ZdoucBioinformatics Group, Wageningen University & Research, Droevendaalsesteeg 1, 6708 PB Wageningen, the Netherlands.ORCID 0000-0001-6534-6609
David MeijerBioinformatics Group, Wageningen University & Research, Droevendaalsesteeg 1, 6708 PB Wageningen, the Netherlands.ORCID 0000-0001-6406-4394
Barbara R TerlouwBioinformatics Group, Wageningen University & Research, Droevendaalsesteeg 1, 6708 PB Wageningen, the Netherlands.ORCID 0000-0002-4058-6718
Justin J J van der HooftBioinformatics Group, Wageningen University & Research, Droevendaalsesteeg 1, 6708 PB Wageningen, the Netherlands.ORCID 0000-0002-9340-5511
Nadine ZiemertInterfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT), Interfaculty Institute for Biomedical Informatics (IBMI), University of Tübingen, Auf der Morgenstelle 24, 72076 Tübingen, Germany.ORCID 0000-0002-7264-1857
Eric J N HelfrichInstitute of Molecular Bio Science, Goethe-University Frankfurt, Max-von-Laue-Straße 9, 60438 Frankfurt am Main, Germany.ORCID 0000-0001-8751-3279
Joleen MasscheleinVIB-KU Leuven Center for Microbiology, Kasteelpark Arenberg 31, 3001 Leuven, Belgium.ORCID 0000-0003-4366-3675
Christophe CorreSchool of Life Sciences, University of Warwick, Coventry CV4 7AL, United Kingdom.ORCID 0000-0002-4292-9315
Marc G ChevretteDepartment of Microbiology and Cell Science, University of Florida, 1355 Museum Dr, Gainesville, FL 32603, United States.ORCID 0000-0002-7209-0717
Gilles P van WezelInstitute of Biology, Leiden University, Sylviusweg 72, 2333 BE Leiden, the Netherlands.ORCID 0000-0003-0341-1561
Marnix H MedemaInstitute of Biology, Leiden University, Sylviusweg 72, 2333 BE Leiden, the Netherlands.ORCID 0000-0002-2191-2821
Tilmann WeberThe Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2950 Kongens Lyngby, Denmark.ORCID 0000-0002-8260-5120

Funding

Integrative Multidisciplinary Discovery Platform to Unlock Marine Natural Products Therapeutic OpportunitiesRM1GM145426 · NIGMS · UNIVERSITY OF FLORIDA · PI Mohamed Abou Donia, Steven D Bruner · 2022 to 2026
$8.8M
Synthesis and function of Queuosine in BacteriaR01GM070641 · NIGMS · UNIVERSITY OF FLORIDA · PI DE CRECY-LAGARD, VALERIE A · 2006 to 2023
$5.3M
Danish National Research Foundation DNRF137ERC 101055020ERC OCENW.XL21.XL21.088FWO G061821NFWO I008520NGerman Center for Infection Research TTU09.716German Research Foundation 504947087Hessian Ministry for Science and the ArtsHorizon 2020 101000392Horizon 2020 948770Horizon Europe Programme MSC 101072485Microbial Secondary MetabolitesNIGMS NIH HHS R01 GM070641NIGMS NIH HHS RM1 GM145426NIH HHS RM1GM145426Novo Nordisk Foundation NNF20CC0035580Novo Nordisk Foundation NNF22OC0079021NWO KICH1.LWV04.21.013The Royal Thai GovernmentTranslational Biodiversity Genomics
6 · The paper itself

Abstract

Microorganisms synthesize small bioactive compounds through their secondary or specialized metabolism. Those compounds play an important role in microbial interactions and soil health, but are also crucial for the development of pharmaceuticals or agrochemicals. Over the past decades, advancements in genome sequencing have enabled the identification of large numbers of biosynthetic gene clusters directly from microbial genomes. Since its inception in 2011, antiSMASH (https://antismash.secondarymetabolites.org/), has become the leading tool for detecting and characterizing these gene clusters in bacteria and fungi. This paper introduces version 8 of antiSMASH, which has increased the number of detectable cluster types from 81 to 101, and has improved analysis support for terpenoids and tailoring enzymes, as well as improvements in the analysis of modular enzymes like polyketide synthases and nonribosomal peptide synthetases. These modifications keep antiSMASH up-to-date with developments in the field and extend its overall predictive capabilities for natural product genome mining.

Indexed as

Genetic TechniquesMultigene FamilyPeptide SynthasesPolyketide SynthasesSoftwareTerpenesnon-ribosomal peptide synthasePeptide SynthasesPolyketide SynthasesTerpenes

Identifiers

PMID40276974
PMCPMC12230676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.